| [1] |
Zhang L, Wang F, Wang L，et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
|
| [2] |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013, 310(9): 948-959.
|
| [3] |
Gao Y, Chen G, Tian H, et al. Prevalence of hypertension in china: a cross-sectional study [J]. PLoS One, 2013, 8(6): e65938.
|
| [4] |
Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population [J]. Clin Exp Nephrol, 2009, 13(6): 621-630.
|
| [5] |
Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006 [J]. Am J Kidney Dis, 2006, 48 (Suppl 1): S2-S90.
|
| [6] |
Wright S, Klausner D, Baird B, et al. Timing of dialysis initiation and survival in ESRD [J]. Clin J Am Soc Nephrol, 2010, 5(10): 1828-1835.
|
| [7] |
Clark WF, Na Y, Rosansky SJ, et al. Association between estimated glomerular filtration rate at initiation of dialysis and mortality [J]. CMAJ, 2011, 183(1): 47-53.
|
| [8] |
Hwang SJ, Yang WC, Lin MY, et al. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan [J]. Nephrol Dial Transplant, 2010, 25(8): 2616-2624.
|
| [9] |
Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis [J]. N Engl J Med, 2010, 363(7): 609-619.
|
| [10] |
Quinn RR, Ravani P. Fistula-first and catheter-last: fading certainties and growing doubts [J]. Nephrol Dial Transplant, 2014, 29(4): 727-730.
|
| [11] |
Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review [J]. J Am Soc Nephrol, 2013, 24(3): 465-473.
|
| [12] |
Battistella M, Bhola C, Lok CE. Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report [J]. Am J Kidney Dis, 2011, 57(3): 432-441.
|
| [13] |
Blake PG, Quinn RR, Oliver MJ. Peritoneal dialysis and the process of modality selection [J]. Perit Dial Int, 2013, 33(3): 233-241.
|
| [14] |
Konner K, Hulbert-Shearon TE, Roys EC, et al. Tailoring the initial vascular access for dialysis patients [J]. Kidney Int, 2002, 62(1): 329-338.
|
| [15] |
Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women's health initiative limited access dataset and meta-analysis [J]. BMJ, 2011, 342：d2040.
|
| [16] |
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J]. Am J Kidney Dis, 2005, 45(4 Suppl 3): S1-S153.
|
| [17] |
Tentori F, Hunt WC, Rohrscheib M, et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization [J]? J Am Soc Nephrol, 2007, 18(8): 2377-2384.
|
| [18] |
Robinson BM, Tong L, Zhang J, et al. Blood pressure levels and mortality risk among hemodialysis patients in the dialysis outcomes and practice patterns study [J]. Kidney Int, 2012, 82(5): 570-580.
|
| [19] |
Hörl WH. Hypertension in end-stage renal disease: different measures and their prognostic significance [J]. Nephrol Dial Transplant, 2010, 25(10): 3161-3166.
|
| [20] |
Chang TI, Friedman GD, Cheung AK, et al. Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study [J]. J Hum Hypertens, 2011, 25(2): 98-105.
|
| [21] |
Agarwal R. Managing hypertension using home blood pressure monitoring among haemodialysis patients--a call to action [J]. Nephrol Dial Transplant, 2010, 25(6): 1766-1771.
|
| [22] |
Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population [J]. Nephrol Dial Transplant, 2011, 26(6): 1948-1955.
|
| [23] |
Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study [J]. Nephrol Dial Transplant, 2011, 26(6): 1938-1947.
|
| [24] |
Kalantar-Zadeh K, Shah A, Duong U, et al. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals [J]. Kidney Int, 2010, Suppl 117: S10-S21.
|
| [25] |
Dukkipati R, Kovesdy CP, Colman S, et al. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients [J]. J Ren Nutr, 2010, 20(4): 243-254.
|
| [26] |
Nakai S, Akiba T, Kazama J, et al. Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan [J]. Ther Apher Dial, 2008, 12(1): 49-54.
|
| [27] |
Souberbielle JC, Boutten A, Carlier MC, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients [J]. Kidney Int, 2006, 70(2): 345-350.
|